269 related articles for article (PubMed ID: 35583844)
21. Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis.
Oladipupo SS; Smith C; Santeford A; Park C; Sene A; Wiley LA; Osei-Owusu P; Hsu J; Zapata N; Liu F; Nakamura R; Lavine KJ; Blumer KJ; Choi K; Apte RS; Ornitz DM
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13379-84. PubMed ID: 25139991
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
Brooks AN; Kilgour E; Smith PD
Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
[TBL] [Abstract][Full Text] [Related]
23. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
24. Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades.
Hoshi T; Watanabe Miyano S; Watanabe H; Sonobe RMK; Seki Y; Ohta E; Nomoto K; Matsui J; Funahashi Y
Biochem Biophys Res Commun; 2019 May; 513(1):1-7. PubMed ID: 30944079
[TBL] [Abstract][Full Text] [Related]
25. Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.
Ruan R; Li L; Li X; Huang C; Zhang Z; Zhong H; Zeng S; Shi Q; Xia Y; Zeng Q; Wen Q; Chen J; Dai X; Xiong J; Xiang X; Lei W; Deng J
Mol Cancer; 2023 Mar; 22(1):60. PubMed ID: 36966334
[TBL] [Abstract][Full Text] [Related]
26. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
[TBL] [Abstract][Full Text] [Related]
27. Therapeutics Targeting FGF Signaling Network in Human Diseases.
Katoh M
Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
[TBL] [Abstract][Full Text] [Related]
28. FGF signaling network in the gastrointestinal tract (review).
Katoh M; Katoh M
Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
[TBL] [Abstract][Full Text] [Related]
29. Targeting FGFR Signaling in Cancer.
Touat M; Ileana E; Postel-Vinay S; André F; Soria JC
Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430
[TBL] [Abstract][Full Text] [Related]
30. FGFR signalling in women's cancers.
Fearon AE; Gould CR; Grose RP
Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
[TBL] [Abstract][Full Text] [Related]
31. Deciphering role of FGFR signalling pathway in pancreatic cancer.
Kang X; Lin Z; Xu M; Pan J; Wang ZW
Cell Prolif; 2019 May; 52(3):e12605. PubMed ID: 30945363
[TBL] [Abstract][Full Text] [Related]
32. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress.
Giacomini A; Taranto S; Rezzola S; Matarazzo S; Grillo E; Bugatti M; Scotuzzi A; Guerra J; Di Trani M; Presta M; Ronca R
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317057
[TBL] [Abstract][Full Text] [Related]
34. The role of fibroblast growth factors in tumor growth.
Korc M; Friesel RE
Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
[TBL] [Abstract][Full Text] [Related]
35. Recent developments and advances of FGFR as a potential target in cancer.
Xue WJ; Li MT; Chen L; Sun LP; Li YY
Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
[TBL] [Abstract][Full Text] [Related]
36. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
[TBL] [Abstract][Full Text] [Related]
37. FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention.
Wang Y; Liu D; Zhang T; Xia L
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802841
[TBL] [Abstract][Full Text] [Related]
38. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
39. Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets.
Wang H; Yang J; Zhang K; Liu J; Li Y; Su W; Song N
Front Pharmacol; 2021; 12():650388. PubMed ID: 33935756
[TBL] [Abstract][Full Text] [Related]
40. FGF/FGFR signaling in health and disease.
Xie Y; Su N; Yang J; Tan Q; Huang S; Jin M; Ni Z; Zhang B; Zhang D; Luo F; Chen H; Sun X; Feng JQ; Qi H; Chen L
Signal Transduct Target Ther; 2020 Sep; 5(1):181. PubMed ID: 32879300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
